noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

The Office of the Governor of the[...]

Governor Stein Spotlights North Carolina’s Leadership in Advanced[...]
NRCS - Natural Resources[...]

Natural Resources Conservation Service Elevates Producer Input Through[...]
Conduent Inc.

CONDUENT INC (2026 PROXY)

Healthcare

Dynamk Capital LLC

03/05/2024 | Press release | Archived content

Bit.bio makes two big announcements in Alzheimer’s and Parkinson’s research and collaboration

Portfolio company bit.bio made two big announcements. In addition to launching a panel of 16 opti-ox™ precision reprogrammed neurodegenerative disease models for research and drug discovery in Alzheimer's and Parkinson's, they announced the first project in a multi-year collaboration agreement with the Michael J. Fox Foundation for Parkinson's Research to generate human cell products for research, and drug discovery in these areas.

Dynamk Capital LLC published this content on March 05, 2024, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on April 06, 2026 at 12:14 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format